March 3, 2011Circulation Research109 citations
View Full PaperMolecular Imaging of Coronary Atherosclerosis and Myocardial Infarction
Key Result
Cardiovascular molecular imaging, including hybrid protocols such as FMT-CT and PET-MRI, shows potential for targeting coronary atherosclerosis and facilitating preventive patient care.
Structured PICO
I
Intervention
Cardiovascular molecular imaging (including fluorescence imaging, FMT-CT, and PET-MRI)
This review outlines the potential of cardiovascular molecular imaging, including hybrid protocols like FMT-CT and PET-MRI, to transform preclinical research and clinical care for coronary atherosclerosis and heart failure.
Abstract
Motivated by the promise to transform preclinical research and clinical care, cardiovascular molecular imaging has made advances toward targeting coronary atherosclerosis and heart failure. Here, we discuss recent progress in the field, highlight how molecular imaging may facilitate preventive patient care, and review specific challenges associated with coronary and heart failure imaging. Practical considerations stress the potential of fluorescence imaging for basic research and discuss hybrid protocols such as FMT-CT and PET-MRI.
Cite This Study
Leuschner et al. (Thu,) conducted a review in Coronary atherosclerosis and heart failure. Cardiovascular molecular imaging was evaluated. Cardiovascular molecular imaging, including hybrid protocols such as FMT-CT and PET-MRI, shows potential for targeting coronary atherosclerosis and facilitating preventive patient care.